The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs

By Schwebel Hervéé J.   van Hoogevest Peter   Leigh Mathew L.S.   Kuentz Martin  

Pharmaceutical Development and Technology, Vol. 16, Iss. 3, 2011-06 ,pp. : 278-286

Informa Healthcare

Access to resources Recommend Favorite

Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug

By Carlert Sara   Pålsson Anna   Hanisch Gunilla   Corswant Christian   Nilsson Catarina   Lindfors Lennart   Lennernäs Hans   Abrahamsson Bertil  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2119-2130

Springer Publishing Company

Access to resources Recommend Favorite

An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system

By Li Hong   Jin Hyo-Eon   Shim Won-Sik   Shim Chang-Koo  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 10, 2013-10 ,pp. : 1515-1522

Informa Healthcare

Access to resources Recommend Favorite

Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives

By  

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1004-1020

Bentham Science Publishers

Access to resources Recommend Favorite

The biopharmaceutics classification system (BCS): Class III drugs - better candidates for BA/BE waiver?

By Blume H.H.   Schug B.S.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 2, 1999-12 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite